MedCity FemFwd Why women's health is a scalable sector
Feb 1, 2026
Anna Jeter, co-founder and chief regulatory officer of AOA Dx and ovarian cancer diagnostic developer. She discusses a report showing women's health is scalable with $100B+ in exits and 27 unicorns. Diagnostics, especially screening and oncology, are highlighted as anchors. The conversation urges investors and entrepreneurs to see women's health as a broad, capital-efficient market with major M&A and IPO activity.
AI Snips
Chapters
Transcript
Episode notes
Women's Health Is Already Big Business
- Women's health is already a scaled, profitable healthcare category with proven exits and buyers.
- AOADX found over $100 billion in realized exits and 27 unicorns, disproving the 'niche' myth.
Founders' Personal Exit Experience
- Anna and her cofounder had personally experienced multiple successful women's health exits.
- Their firsthand history motivated them to compile data showing the market's proven performance.
Exit Pace Is Picking Up
- Exits are accelerating: nearly half occurred in the last five years.
- This trend shows companies founded in the last 5–10 years are now delivering significant returns.